In humans with heart failure, plasma concentrations of HSPA1 increase gradually with the progression of disease stages; therefore, HSPA1 could be used as a potential screening biomarker for the early diagnosis of heart failure [40]. The gene discussed is HSPA1A; the disease is heart failure.